St. Jude Medical (STJ) Cash Flow Statement

Click line-items for a historical chart and %

Net earnings
Depreciation and amortization
Amortization of debt discount (premium)
Inventory step-up amortization
Stock-based compensation	83M
Excess tax benefits from stock-based compensation
Purchased in-process research and development charges
Deferred income taxes	-58M
Accounts receivable	-17M
Inventories	-24M
Other current assets	21M
Accounts payable and accrued expenses	28M
Income taxes payable
Other, net	110M
Net cash provided by operating activities	905M
Purchases of property, plant and equipment	-189M
Business acquisition payments, net of cash acquired	-21M
Other, net	-5M
Net cash used in investing activities	-215M
Proceeds from exercise of stock options and stock issued	73M
Excess tax benefits from stock-based compensation	9M
Common stock repurchased, including related costs	0
Dividends paid	-258M
Issuances/payments of commercial paper borrowings, net	-408M
Borrowings under debt facilities	500M
Payments under debt facilities	-759M
Net cash provided by (used in) financing activities	-975M
Effect of currency exchange rate changes on cash and cash equivalents	12M
Net increase in cash and cash equivalents	-273M
Cash and cash equivalents at beginning of period	667M
Cash and cash equivalents at end of period	394M

Entities mentioned with STJ

View All Entities